Daily FNArena News - Australia

Fisher & Paykel Healthcare has extended its track record of beating guidance with a robust FY16 result and brokers expect more of the same in FY17.

The results of the Australian Investors’ Sentiment Survey for May are in and they show investors have become even more cautious.

Weekly Update on ASX-listed companies buying in their own stock.

Flexigroup has announced the divestment or discontinuing of several non-core businesses, flagging a mild downgrade to FY16 expectations. Brokers expect better returns and risk profile ahead.

Small discretionary retailers are feeling chill winds and brokers shuffle their views on the outlook for the next few months.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Wesfarmers has outlined large impairments on Target and Curragh coal mine to be taken in the FY16 accounts. Brokers were not surprised but some question whether a dividend reduction is in the offing.

FNArena’s weekly update on short positions in the Australian share market.

Weekly Update on ASX-listed companies buying in their own stock.

Brokers are unconcerned about a fall in first half profit for Technology One, given strong revenue growth and contract pipeline. The main issue they perceive is one of valuation.